ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2024 Sustainability Report
Company: ImmuneOnco Biopharmaceuticals (Shanghai) Inc
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 39
The report describes Board-led sustainability oversight supported by an ESG working group. It reports 156 employees at the end of 2024, including 93 female employees. Environmental disclosures include 2,126.78 tonne of total Scope 1 and Scope 2 GHG emissions and 3,521.37 kWh in '000s of total energy consumption. The company also reports zero workplace fatalities for three consecutive years and describes extensive compliance, safety, employee development and healthcare-accessibility initiatives.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.